137 related articles for article (PubMed ID: 26118112)
1. [Design, synthesis and anti-platelet aggregation activities of ligustrazine-tetrahydroisoquinoline derivatives].
Xie D; Zhang EL; Li JM; Wang J; He GW
Yao Xue Xue Bao; 2015 Mar; 50(3):326-31. PubMed ID: 26118112
[TBL] [Abstract][Full Text] [Related]
2. [Design, synthesis, and biological evaluation of phenylpropenamides compounds as anti-platelet aggregation].
Yang Y; Zuo J; Li JM; Ma XD; Zhang YC; Huang WJ
Yao Xue Xue Bao; 2017 Jan; 52(1):120-5. PubMed ID: 29911807
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and biological evaluation of novel chalcone aromatic oxygen alkyl acids compounds].
Huang WJ; Xie D; Li JM; Zhang YC; Zuo J; Liu HC
Yao Xue Xue Bao; 2016 Apr; 51(4):600-5. PubMed ID: 29859530
[TBL] [Abstract][Full Text] [Related]
4. Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.
Krysko AA; Krysko OL; Kabanova TA; Andronati SA; Kabanov VM
Bioorg Med Chem Lett; 2010 Aug; 20(15):4444-6. PubMed ID: 20598885
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
Yang J; Hua WY; Wang FX; Wang ZY; Wang X
Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
[TBL] [Abstract][Full Text] [Related]
6. Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents.
Chen H; Li G; Zhan P; Liu X
Eur J Med Chem; 2011 Nov; 46(11):5609-15. PubMed ID: 21993151
[TBL] [Abstract][Full Text] [Related]
7. Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents.
Cheng XC; Liu XY; Xu WF; Guo XL; Zhang N; Song YN
Bioorg Med Chem; 2009 Apr; 17(8):3018-24. PubMed ID: 19329327
[TBL] [Abstract][Full Text] [Related]
8. 2-Substituted (S)-2-(3,3-dimethyl-1-oxo-10,10a-dihydroimidazo[1,5-b]isoquinolin-2(1H,3H,5H)-yl)acetic acids: Conformational prediction, synthesis, anti-thrombotic and vasodilative evaluation.
Wang H; Peng L; Zhao M; Liu J; Zhang X; Wang Y; Wu J; Li L; Peng S
Bioorg Med Chem; 2011 Jan; 19(2):871-82. PubMed ID: 21193315
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis of ferulic acid derivatives and their inhibitory effect on platelet aggregation].
Li JM; Zhao YH; Zhong GC; Long ZJ; Zhou P; Yuan M
Yao Xue Xue Bao; 2011 Mar; 46(3):305-10. PubMed ID: 21626785
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis of thienopyridine derivatives and its anti-platelet activity in vivo].
Zhou YS; Wang PB; Liu Y; Chen JF; Yue N; Liu DK
Yao Xue Xue Bao; 2011 Jan; 46(1):70-4. PubMed ID: 21465811
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Pharmacological Evaluation of Novel Piperlongumine derivatives as Potential Antiplatelet Aggregation Candidate.
Wang Y; Wang J; Li J; Zhang Y; Huang W; Zuo J; Liu H; Xie D; Zhu P
Chem Biol Drug Des; 2016 Jun; 87(6):833-40. PubMed ID: 26706668
[TBL] [Abstract][Full Text] [Related]
13. [Design, synthesis of novel N, N'-bis-(halogenophenyl)-4- methoxybenzene-1, 3-disulfonamides and evaluation of their anti-platelet aggregation activity].
Li GA; Wang X; Meng X; Lin YB; Li X; Liu XJ
Yao Xue Xue Bao; 2015 Feb; 50(2):185-90. PubMed ID: 25975026
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents.
Li HX; Tian JH; Li HY; Wan X; Zou Y
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110589
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological activities of novel Ligustrazine derivatives.
Cheng XC; Liu XY; Xu WF; Guo XL; Ou Y
Bioorg Med Chem; 2007 May; 15(10):3315-20. PubMed ID: 17383884
[TBL] [Abstract][Full Text] [Related]
16. Anti-platelet aggregation activity of some pyrazines.
Ohta A; Takahashi H; Miyata N; Hirono H; Nishio T; Uchino E; Yamada K; Aoyagi Y; Suwabe Y; Fujitake M; Suzuki T; Okamoto K
Biol Pharm Bull; 1997 Oct; 20(10):1076-81. PubMed ID: 9353568
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity.
Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Amidi S; Kobarfard F
Chem Pharm Bull (Tokyo); 2013; 61(2):144-50. PubMed ID: 23154304
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors.
Tian X; Wang LY; Xia S; Li ZB; Liu XH; Yuan Y; Fang L; Zuo H
Bioorg Med Chem Lett; 2012 Jan; 22(1):204-6. PubMed ID: 22137848
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of 4-methoxy-3-arylamido-N-(substitutedphenyl)benzamide derivatives as potential antiplatelet agents.
Liu X; Chen X; Qiu K; Zhang Z
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900231. PubMed ID: 31808975
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamides.
Liu XJ; Shi XX; Zhong YL; Liu N; Liu K
Bioorg Med Chem Lett; 2012 Nov; 22(21):6591-5. PubMed ID: 23010272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
